Advertisement

Topics

KellBenx Locks Up $2.5 Million Seed Round

09:04 EDT 21 Apr 2011 |

KellBenx, a New York-based company developing prenatal diagnostic tests, raised $2.5 million from four investors, according to a press release. The announcement came just days after KellBenx secured an agreement with Cedars-Sinai Medical Center to develop a new blood test designed to predict the risk of premature births early in pregnancy. The test may even [...]

Original Article: KellBenx Locks Up $2.5 Million Seed Round

NEXT ARTICLE

More From BioPortfolio on "KellBenx Locks Up $2.5 Million Seed Round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...